ATE331784T1 - Verfahren zur diagnose von fettsucht - Google Patents

Verfahren zur diagnose von fettsucht

Info

Publication number
ATE331784T1
ATE331784T1 AT02293085T AT02293085T ATE331784T1 AT E331784 T1 ATE331784 T1 AT E331784T1 AT 02293085 T AT02293085 T AT 02293085T AT 02293085 T AT02293085 T AT 02293085T AT E331784 T1 ATE331784 T1 AT E331784T1
Authority
AT
Austria
Prior art keywords
obesity
diagnosis
polymorphisms
therapy
identification
Prior art date
Application number
AT02293085T
Other languages
English (en)
Inventor
Philippe Boutin
Severine Dubois
Christian Dina
Philippe Froguel
Original Assignee
Centre Nat Rech Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Nat Rech Scient filed Critical Centre Nat Rech Scient
Application granted granted Critical
Publication of ATE331784T1 publication Critical patent/ATE331784T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/044—Hyperlipemia or hypolipemia, e.g. dyslipidaemia, obesity

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT02293085T 2002-12-13 2002-12-13 Verfahren zur diagnose von fettsucht ATE331784T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02293085A EP1428875B1 (de) 2002-12-13 2002-12-13 Verfahren zur Diagnose von Fettsucht

Publications (1)

Publication Number Publication Date
ATE331784T1 true ATE331784T1 (de) 2006-07-15

Family

ID=32319694

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02293085T ATE331784T1 (de) 2002-12-13 2002-12-13 Verfahren zur diagnose von fettsucht

Country Status (9)

Country Link
US (1) US20060269919A1 (de)
EP (2) EP1428875B1 (de)
JP (1) JP2006509519A (de)
AT (1) ATE331784T1 (de)
AU (1) AU2003276616A1 (de)
CA (1) CA2509831A1 (de)
DE (1) DE60212861T2 (de)
ES (1) ES2266432T3 (de)
WO (1) WO2004055180A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2087789A1 (de) 2008-02-06 2009-08-12 Heinrich-Heine-Universität Düsseldorf FTO-modifiziertes nichtmenschliches Säugetier
WO2010131491A1 (ja) 2009-05-15 2010-11-18 国立大学法人東京大学 肥満素因の評価方法及びキット、並びに、抗肥満薬及びそのスクリーニング方法、非ヒト動物、脂肪組織、脂肪細胞、トランスジェニックマウス作成方法、抗原、抗体

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6528699B1 (en) * 1997-02-25 2003-03-04 Genzyme Transgenics Corporation Transgenically produced non-secreted proteins
WO2000025798A1 (en) * 1998-11-05 2000-05-11 Thomas Jefferson University Treatment of parkinson's disease with oligonucleotides
JP4219617B2 (ja) * 2001-06-15 2009-02-04 独立行政法人科学技術振興機構 グリーン蛍光タンパク質遺伝子により形質転換されたトランスジェニック動物

Also Published As

Publication number Publication date
AU2003276616A1 (en) 2004-07-09
DE60212861D1 (de) 2006-08-10
EP1428875A1 (de) 2004-06-16
US20060269919A1 (en) 2006-11-30
ES2266432T3 (es) 2007-03-01
WO2004055180A1 (en) 2004-07-01
EP1572999A1 (de) 2005-09-14
CA2509831A1 (en) 2004-07-01
EP1428875B1 (de) 2006-06-28
DE60212861T2 (de) 2007-03-01
JP2006509519A (ja) 2006-03-23

Similar Documents

Publication Publication Date Title
DE60035163D1 (de) Abc1 polypeptide und verfahren und reagenzien zur modulation des cholesterolgehalts
IN2015KN00290A (de)
ATE435012T1 (de) Verfahren zur behandlung von parkinson-krankheit
DE60333963D1 (de) Zytokin Ligand zur Behandlung von Asthma und Atemwegsüberreaktivität
BRPI0407207A (pt) Método para tratar, prevenir e diagnosticar uma infecção por heliocobacter
EP1576108A4 (de) Nitrilasen, diese codierende nukleinsäuren sowie verfahren zur herstellung und verwendung davon
ATE474847T1 (de) Verfahren zur herstellung von dipeptiden
ATE392430T1 (de) Verfahren zur herstellung von dipeptiden
EP1652923A4 (de) Bei krebs überexprimiertes gen
WO2003007803A3 (en) Methods for diagnosing and treating alzheimer's disease and parkinson's disease
DK1515752T3 (da) ACE2-aktivering til behandling af hjerte-, lunge- og nyresygdomme og hypertension
DE60326748D1 (de) Verfahren zur identifizierung des brustkrebsrisikos
ATE447561T1 (de) Substituierte aryl 1,4-pyrazin derivate
DE60028544D1 (de) Prostata-spezifische gene zur diagnose, prognose und behandlung von prostata-krebs
DE60323994D1 (de) Verfahren zur herstellung von 2-chlor-1,1,1,2,3,3,3-heptafluorpropan, hexafluorpropen und 1,1,1,2,3,3,3-heptafluorpropan
WO2004043232A3 (en) Methods for identifying risk of melanoma and treatments thereof
DE60330262D1 (de) Vorrichtung zur erleichterung und authentifizierung von transaktionen
EP1689347A4 (de) Verfahren und reagenzien zur behandlund prävention und diagnose von bunyavirus infektion
ATE356995T1 (de) Verfahren zur identifizierung von mitteln zur behandlung von diabetes
DE60209541D1 (de) Verfahren zur herstellung von sekundären und tertiären aminofunktionellensilanen, iminoorganosilanen und/oder imidoorganosilanen
ATE400560T1 (de) Verfahren zur herstellung von 10,11 dihydro 10 hydroxy 5h-dibenz/b,f/azepin-5-carbonsäureamid und 10,11 dihydro 10 oxo-5h-dibenz/b,f/azepin-5 carbonsäureamid
ATE402684T1 (de) Elastische befestigungslasche, befestigungssystem und verfahren zur herstellung davon
WO2005027710A3 (en) Methods for identifying subjects at risk of melanoma and treatments thereof
GB0228337D0 (en) Replication protein
DE60212861D1 (de) Verfahren zur Diagnose von Fettsucht

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties